摘要
以LWCT(全血凝固时间)进行监测,以体重决定肝素用量来预防血液透析过程中,出血和凝血合并症的方法被许多医院广泛采用。我们现在仅仅以LWCT监测、决定肝素用量,它能使肝素量更接近于肝素个体化量。
The method that the doses of heparin are monitored by LWCT and de-cided by body weight is widely adopted by most hosptals to prevent coagulation andhaemorrhage. Now, We Use another method that the doses of heparin are moni-tored decidedonly by LWCT. It can make the doses of heparin approach heparin'sindividulization and decrease the amalgumation illness of coagulation and haemor- rhage in hemodialysis.
出处
《航空航天医药》
1994年第2期80-81,共2页
Aerospace Medicine